Resmed Inc (RMD) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2026, Resmed reported revenue of $5.65B, up 9.9% from $5.15B the year before. Net income was $1.52B (a 26.9% net margin), or $10.43 per diluted share. Gross margin was 61.1% and operating margin was 33.4%. Operating activities generated $1.81B of cash, leaving $1.65B of free cash flow. At fiscal year end, Resmed held $8.97B in total assets against $2.38B in total liabilities, including $1.47B of cash and equivalents.
Open the full interactive Resmed financials → Quarterly statements, key ratios, valuation history and price charts.
Resmed Key Stats
| Share Price | $235.04 |
|---|---|
| Market Cap | $34.33B |
| P/E Ratio | 22.5 |
| Dividend Yield | 1.02% |
| Revenue YoY Growth | +9.8% |
| 52-Week Range | $182.30 – $273.72 |
| Shares Outstanding | 145.5 million (basic, 2026 Q4) |
Resmed Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $3.20B | $3.58B | $4.22B | $4.69B | $5.15B | $5.65B |
| Cost of Goods Sold | $1.36B | $1.55B | $1.87B | $2.03B | $2.09B | $2.20B |
| Gross Profit | $1.84B | $2.02B | $2.36B | $2.66B | $3.05B | $3.45B |
| Operating Income | $903.7M | $1.00B | $1.13B | $1.32B | $1.69B | $1.89B |
| Pre-Tax Income | $883.7M | $960.5M | $1.10B | $1.26B | $1.68B | $1.92B |
| Income Tax | $409.2M | $181.0M | $204.1M | $243.8M | $276.8M | $396.1M |
| Net Income | $474.5M | $779.4M | $897.6M | $1.02B | $1.40B | $1.52B |
| Diluted EPS | $3.24 | $5.30 | $6.09 | $6.92 | $9.51 | $10.43 |
Resmed Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $1.34B | $1.42B | $1.43B | $1.46B |
| Net Income | $348.5M | $392.6M | $398.7M | $383.4M |
| Diluted EPS | $2.37 | $2.68 | $2.74 | $2.63 |
Resmed Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $295.3M | $273.7M | $227.9M | $238.4M | $1.21B | $1.47B |
| Current Assets | $1.57B | $1.93B | $2.37B | $2.36B | $3.51B | $4.32B |
| Total Assets | $4.73B | $5.10B | $6.75B | $6.87B | $8.17B | $8.97B |
| Current Liabilities | $911.8M | $689.3M | $758.5M | $910.7M | $1.02B | $1.40B |
| Total Long-Term Debt | $643.4M | $765.3M | $1.43B | $697.3M | $658.4M | $399.4M |
| Total Liabilities | $1.84B | $1.74B | $2.62B | $2.01B | $2.21B | $2.38B |
| Shareholders' Equity | $2.89B | $3.36B | $4.13B | $4.86B | $5.97B | $6.59B |
Resmed Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $736.7M | $351.1M | $693.3M | $1.40B | $1.75B | $1.81B |
| Cash From Investing | -$158.5M | -$229.9M | -$1.16B | -$269.8M | -$200.0M | -$545.2M |
| Cash From Financing | -$764.6M | -$128.4M | $422.9M | -$1.12B | -$606.3M | -$1.01B |
| Free Cash Flow | $634.0M | $216.3M | $573.6M | $1.30B | $1.66B | $1.65B |
| Dividends Paid | $226.7M | $245.3M | $258.3M | $282.3M | $310.9M | $349.7M |
Figures from Resmed's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Resmed financials page for every line item.
Resmed Company Profile
| Ticker | RMD |
|---|---|
| Exchange | NYSE, OTC |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | San Diego, California |
| Incorporated in | Delaware |
| Fiscal Year End | June 30 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000943819 |
Frequently Asked Questions
What was Resmed's revenue in fiscal 2026?
Resmed (RMD) reported revenue of $5.65B for fiscal 2026.
What is Resmed's annual revenue history?
Resmed's annual revenue by fiscal year: 2021: $3.20B; 2022: $3.58B; 2023: $4.22B; 2024: $4.69B; 2025: $5.15B; 2026: $5.65B.
What was Resmed's net income in fiscal 2026?
Resmed reported net income of $1.52B for fiscal 2026.
What was Resmed's earnings per share (EPS) in fiscal 2026?
Resmed's diluted EPS was $10.43 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Resmed generate in fiscal 2026?
Resmed generated $1.65B of free cash flow in fiscal 2026.
What was Resmed's revenue last quarter?
In its most recent reported quarter (2026 Q4), Resmed reported revenue of $1.46B.
How much debt does Resmed have?
Resmed reported $399.4M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Resmed are outstanding?
Resmed reported a weighted average of 145.5 million basic shares outstanding in 2026 Q4.
What is Resmed's market cap?
Based on its latest closing price, Resmed (RMD) has a market capitalization of about $34.33B.
When does Resmed's fiscal year end?
Resmed's fiscal year end, as registered with the SEC, is June 30.
Where is Resmed headquartered?
Resmed lists its business address in San Diego, California in its SEC filings.